- Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply CNBC
- Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Investors | Eli Lilly and Company
- Eli Lilly lowers Zepbound price and Harris campaign hits Trump on fiscal agenda: Morning Rundown NBC News
- Eli Lilly to sell Zepbound directly to consumers without insurance coverage ABC News
- Lilly launches lower-price weight loss drug without injector pen CNN